People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mahzi Therapeutics Inc. | — | Biotechnology | Series C | $52.6M | $1.3B | 2021 |
| Cerebral Therapeutics, Inc. | — | Pharmaceuticals | Series B | $31.0M | $680.1M | 2018 |
Stephen Farr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Farr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Camille Samuels | 1 | 6 |
| MATTHEW HAMMOND | 1 | 5 |
| Mahendra Shah | 1 | 5 |
| Shalini Sharp | 1 | 4 |
| Warren Lammert | 1 | 3 |
| Marten Steen | 1 | 3 |
| Daniel Abrams | 1 | 3 |
| Yael Weiss | 1 | 1 |
| Weston Nichols | 1 | 1 |
| Shah Mahendra | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.